Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
Jun 03, 16:00
Abliva Cash from Operations (TTM): -2.578M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -2.578M |
December 31, 2023 | -0.7369M |
September 30, 2023 | -2.074M |
June 30, 2023 | -11.25M |
March 31, 2023 | -14.17M |
December 31, 2022 | -15.91M |
September 30, 2022 | -19.42M |
June 30, 2022 | -13.17M |
March 31, 2022 | -14.15M |
December 31, 2021 | -13.33M |
September 30, 2021 | -9.483M |
June 30, 2021 | -8.115M |
March 31, 2021 | -6.070M |
December 31, 2020 | -7.379M |
September 30, 2020 | -8.684M |
June 30, 2020 | -8.531M |
March 31, 2020 | -8.370M |
December 31, 2019 | -7.666M |
September 30, 2019 | -6.898M |
June 30, 2019 | -6.30M |
March 31, 2019 | -8.022M |
December 31, 2018 | -7.354M |
September 30, 2018 | -6.713M |
June 30, 2018 | -7.611M |
March 31, 2018 | -6.884M |
Date | Value |
---|---|
December 31, 2017 | -6.820M |
September 30, 2017 | -7.304M |
June 30, 2017 | -6.185M |
March 31, 2017 | -6.402M |
December 31, 2016 | -6.726M |
September 30, 2016 | -7.385M |
June 30, 2016 | -7.905M |
March 31, 2016 | -7.006M |
December 31, 2015 | -7.974M |
September 30, 2015 | -6.233M |
June 30, 2015 | -6.206M |
March 31, 2015 | -6.483M |
December 31, 2014 | -6.387M |
September 30, 2014 | -6.818M |
June 30, 2014 | -6.234M |
March 31, 2014 | -4.842M |
December 31, 2013 | -2.932M |
September 30, 2013 | -2.780M |
June 30, 2013 | -2.152M |
March 31, 2013 | -2.376M |
December 31, 2012 | -1.806M |
September 30, 2012 | -1.501M |
June 30, 2012 | -1.516M |
March 31, 2012 | -1.232M |
December 31, 2011 | -1.325M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-19.42M
Minimum
Sep 2022
-0.7369M
Maximum
Dec 2023
-9.214M
Average
-8.451M
Median
Cash from Operations (TTM) Benchmarks
Karolinska Development AB | -2.114M |
Calliditas Therapeutics AB | -37.91M |
Oncopeptides AB | -30.00M |
Olink Holding AB | -42.12M |
BioInvent International AB | -31.06M |